Bevatas 400mg Bevacizumab Injection

Bevatas 400mg Bevacizumab Injection is a prescription targeted anti-cancer medication used in the treatment of various cancers, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It contains Bevacizumab, a monoclonal antibody that works by blocking vascular endothelial growth factor (VEGF), a protein responsible for the formation of new blood vessels that tumors need to grow and spread. By reducing the blood supply to cancer cells, Bevatas 400mg Bevacizumab Injection helps slow tumor progression and supports effective cancer management. Administered as an intravenous infusion under the supervision of an oncology specialist, it is commonly used in combination with chemotherapy or other cancer treatments. Regular monitoring during therapy is important to assess treatment response and manage potential side effects. Patients should use Bevatas 400mg Bevacizumab Injection only as directed by their healthcare provider.